Inactive Instrument

Kamada Ltd. Stock price TEL AVIV STOCK EXCHANGE

Equities

IL0010941198

Pharmaceuticals

Financials

Sales 2024 * 573M 156M 57.34B Sales 2025 * 706M 192M 70.6B Capitalization 1.2B 325M 120B
Net income 2024 * 46M 12.52M 4.6B Net income 2025 * 84M 22.86M 8.4B EV / Sales 2024 * 2.09 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.69 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 54.25%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 55 13-12-08
Founder 73 90-12-12
Director of Finance/CFO 53 17-12-30
Members of the board TitleAgeSince
Director/Board Member 62 19-12-23
Director/Board Member 76 05-04-30
Founder 73 90-12-12
More insiders
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
More about the company
  1. Stock
  2. Equities
  3. Stock Kamada Ltd.
  4. Stock Kamada Ltd. - TEL AVIV STOCK EXCHANGE